New York City and state destinations were to promptly start utilizing the Johnson and Johnson COVID-19 vaccine once more, officials said Saturday.
The utilization of the one-shot J&J vaccine was to continue for the city’s portable, spring up, and homebound vaccination programs, Mayor Bill de Blasio said.
The declaration came one day after the US Centers for Disease Control and the Food and Drug Administration gave the thumbs up to begin apportioning the vaccine, which was connected to few blood clots in beneficiaries.
The utilization of the J&J vaccine was halted April 13 to assess the dangers. Fifteen women, most under 50, were found to have developed the clots and three passed on.
Federal officials discovered the advantages of the vaccine exceeded the little danger factor.
“I got the Johnson and Johnson vaccine alongside our Health Commissioner Dr. Chokshi. We realize firsthand that the vaccine is protected and compelling, and now it’s simpler than any time in recent memory to get your shot,” de Blasio said.
The city Department of Health couldn’t promptly say at which destinations the J&J vaccine was offered Saturday. A few providers were first going to go through their designation of the Pfizer or Moderna vaccine, which were fill in for J&J while that shot was stopped.
Gov. Andrew Cuomo said Saturday morning that the state “will continue administration of this vaccine at all of our state-run destinations taking effect right now.”
In any case, there was none of the one-shot vaccine at the Javits Center Saturday morning.
“We know it’s returning, however we haven’t been provided guidance,” said Ed Shevlin, a representative for the site.
The state’s vaccine arrangement site showed just the Pfizer vaccine was accessible starting at Saturday evening at all centers across New York.
Manhattan resident Kristen McCormick, 27, was at Javits to get her second shot of Pfizer Saturday. She said she didn’t mind which vaccine she got.
“I’ll get however many shots on a case by case basis,” she said.